Literature DB >> 4148918

Interaction of atropine-like drugs with dopamine-containing neurones in rat brain.

M B Bowers, R H Roth.   

Abstract

1. A variety of atropine-like drugs effective in the treatment of drug-induced extrapyramidal syndromes have been investigated with regard to their interaction with dopamine-containing neurones in rat brain.2. Under some conditions benztropine, trihexyphenidyl, atropine and ethopropazine significantly antagonized the chlorpromazine-induced increase in subcortical concentrations of homovanillic acid.3. Most of the atropine-like drugs investigated also decreased the turnover of dopamine in the subcortex as measured by following the disappearance of dopamine after administration of alpha-methyl-p-tyrosine.4. These findings are suggestive that an imbalance between a dopaminergic and cholinergic system might be closely linked to the pathogenesis of extra-pyramidal movement disorders.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4148918      PMCID: PMC1666006          DOI: 10.1111/j.1476-5381.1972.tb07267.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects.

Authors:  L J DOSHAY; K CONSTABLE; F J AGATE
Journal:  J Am Med Assoc       Date:  1956-02-04

2.  Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid.

Authors:  R H Roth
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

3.  Clinical and pharmacological effects of monoamine precursors or haloperidol in chronic schizophrenia.

Authors:  T Persson; B E Roos
Journal:  Nature       Date:  1968-03-02       Impact factor: 49.962

4.  Diverse central effects of chlorpromazine.

Authors:  R P Maickel
Journal:  Int J Neuropharmacol       Date:  1968-01

5.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

6.  Acid metabolites from monoamines in cerebrospinal fluid of chronic schizophrenics.

Authors:  T Persson; B E Roos
Journal:  Br J Psychiatry       Date:  1969-01       Impact factor: 9.319

7.  Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour.

Authors:  T Armfred; A Randrup
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1968

8.  The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents.

Authors:  A V Juorio; D F Sharman; T Trajkov
Journal:  Br J Pharmacol Chemother       Date:  1966-02

9.  Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1966-11

10.  A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1967-08
View more
  6 in total

1.  On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.

Authors:  R J Stawarz; H Hill; S E Robinson; P Setler; J V Dingell; F Sulser
Journal:  Psychopharmacologia       Date:  1975-08-21

2.  Intracranial self-stimulation in rats as a function of various stimulus parameters. VI. Influence of fentanyl, piritramide, and morphine on medial forebrain bundle stimulation with monopolar electrodes.

Authors:  A Wauquier; C J Niemegeers
Journal:  Psychopharmacologia       Date:  1976-03-16

3.  Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice.

Authors:  K Shibata; K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Cholinergic link in the histamine-mediated increase in homovanillic acid in the rat striatum.

Authors:  J Z Nowak; C Maśliński
Journal:  Agents Actions       Date:  1977-03

5.  Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.

Authors:  M G Ondrusek; C D Kilts; G D Frye; R B Mailman; R A Mueller; G R Breese
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Failure of anticholinergic drugs to antagonize the increase in dopamine seen after gammahydroxybutyric acid and axotomy.

Authors:  G Stock
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.